# EDGAR Filing Document

**Accession Number:** 0001800373
**File Stem:** 0000000000-23-001331
**Filing Date:** 2023-2
**Character Count:** 2694
**Document Hash:** e335758afe46c3e99109f7438084688d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-001331.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0000000000-23-001331

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230209

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GOLDENWELL BIOTECH, INC.
- **CENTRAL INDEX KEY:** 0001800373
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **IRS NUMBER:** 842896086
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 2071 MIDWAY DR.
- **CITY:** TWINSBURG
- **STATE:** OH
- **ZIP:** 44087
- **BUSINESS PHONE:** 440-666-7999

**MAIL ADDRESS:**
- **STREET 1:** 2071 MIDWAY DR.
- **CITY:** TWINSBURG
- **STATE:** OH
- **ZIP:** 44087

## Text-Extract

```

United States securities and exchange commission logo

                      February 9, 2023

       Shuang Liu
       Chief Executive Officer, President, and Director
       Goldenwell Biotech, Inc.
       2071 Midway Drive
       Twinsburg, OH 44087

                                                        Re: Goldenwell Biotech,
Inc.
                                                            Form 10-K for the
Fiscal Year ended December 31, 2021
                                                            Filed April 1, 2022
                                                            File No. 000-56275

       Dear Shuang Liu:

              We have completed our review of your filing. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.

                      Sincerely,

                      Division of Corporation Finance

                      Office of Energy & Transportation

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

February 9, 2023

Shuang Liu
Chief Executive Officer, President, and Director
Goldenwell Biotech, Inc.
2071 Midway Drive
Twinsburg, OH 44087

**Re: Goldenwell Biotech, Inc.**
**Form 10-K for the Fiscal Year ended December 31, 2021**
**Filed April 1, 2022**
**File No. 000-56275**

Dear Shuang Liu:

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,

Division of Corporation Finance
Office of Energy & Transportation